ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Champions Oncology Inc

Champions Oncology Inc (CSBR)

6,43
-0,20
(-3,02%)
Geschlossen 30 Juni 10:00PM
6,17
-0,26
(-4,04%)
Nach Börsenschluss: 1:59AM

Champions Oncology Inc (CSBR) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
6,43
( -3,02% )
Gebot
5,58
Fragen
7,32
Volumen
4.662
6,08 Tagesbereich 6,745
5,50 52-Wochen-Bereich 9,6299
Marktkapitalisierung
Handelsende
6,63
Handelsbeginn
6,54
Letzte Trade
1
@
6.43
Letzter Handelszeitpunkt
Finanzvolumen
US$ 30.059
VWAP
6,4477
Durchschnittliches Volumen (3 Mio.)
US$ 8.467
Ausgegebene Aktien
13.886.826
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-39,01
Gewinn pro Aktie (EPS)
-0,17
Erlöse (LTM)
57,95M
Nettogewinn (LTM)
-2,34M

Über Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-def... Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Hackensack, United States
Gegründet
1985
Champions Oncology Inc is listed in the Healthcare sector of the NASDAQ with ticker CSBR. The last closing price for Champions Oncology was US$6,63. Over the last year, Champions Oncology shares have traded in a share price range of US$ 5,50 to US$ 9,6299.

Champions Oncology currently has 13.886.826 shares in issue. The market capitalisation of Champions Oncology is US$89,29 million. Champions Oncology has a price to earnings ratio (PE ratio) of -39.01.

CSBR Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.07-1.076923076926.575.85579366.34312853CS
40.6310.86206896555.875.670436.22822753CS
120.6110.48109965645.8275.686096.02995444CS
26-0.5-7.215007215016.937.715.577116.14915818CS
52-1.34-17.24581724587.779.62995.5163096.82562519CS
156-0.1-1.531393568156.5311.993.6001220816.74768634CS
260-4.09-38.878326996210.5211.993.6001184736.98786889CS

CSBR - Frequently Asked Questions (FAQ)

What is the current Champions Oncology Inc share price?
The current share price of Champions Oncology Inc is US$ 6,43
How many Champions Oncology Inc shares are in issue?
Champions Oncology Inc has 13.886.826 shares in issue
What is the market cap of Champions Oncology Inc?
The market capitalisation of Champions Oncology Inc is USD 89,29M
What is the 1 year trading range for Champions Oncology Inc share price?
Champions Oncology Inc has traded in the range of US$ 5,50 to US$ 9,6299 during the past year
What is the PE ratio of Champions Oncology Inc?
The price to earnings ratio of Champions Oncology Inc is -39,01
What is the cash to sales ratio of Champions Oncology Inc?
The cash to sales ratio of Champions Oncology Inc is 1,59
What is the registered address of Champions Oncology Inc?
The registered address for Champions Oncology Inc is One University Plaza, Hackensack, New Jersey, 07601
What is the Champions Oncology Inc website address?
The website address for Champions Oncology Inc is www.championsoncology.com
Which industry sector does Champions Oncology Inc operate in?
Champions Oncology Inc operates in the Biotechnology & Life Sciences sector

CSBR Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen